Adverum Biotechnologies, Inc. (ADVM) Earnings History
Net Loss13 years of earnings data (2012–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
Adverum Biotechnologies, Inc. (ADVM) Earnings Overview
As of October 3, 2026, Adverum Biotechnologies, Inc. (ADVM) reported trailing twelve-month net income of -$204M, reflecting -227.7% year-over-year growth. The company earned $-8.70 per diluted share over the past four quarters, with a net profit margin of -13092.7%.
Looking at the long-term picture, ADVM's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2012.
Adverum Biotechnologies, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including OCGN (-$82M net income, -1537.4% margin), EDIT (-$74M net income, -395.0% margin), KRYS ($241M net income, 52.6% margin), ADVM has room to improve margins relative to the peer group. Compare ADVM vs OCGN →
ADVM Earnings vs Peers
Earnings metrics vs comparable public companies
ADVM Historical Earnings Data (2012–2024)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$131M | -7.2% | -$139M | $-6.62 | -13092.7% | -13915.9% |
| 2023 | -$122M | +21.0% | -$129M | $-2.02 | -3392.1% | -3581.7% |
| 2022 | -$155M | -6.2% | -$157M | $-2.67 | - | - |
| 2021 | -$146M | -23.9% | -$146M | $-1.48 | -1940.5% | -1948.3% |
| 2020 | -$118M | -82.2% | -$118M | $-1.26 | - | - |
| 2019 | -$64M | +11.2% | -$69M | $-0.87 | -25794.4% | -27418.0% |
| 2018 | -$73M | -29.4% | -$78M | $-1.18 | -4505.4% | -4843.7% |
| 2017 | -$56M | +50.6% | -$59M | $-1.29 | -3036.6% | -3182.6% |
| 2016 | -$114M | -139.7% | -$115M | $-3.14 | -7817.7% | -7923.3% |
| 2015 | -$47M | -86.8% | -$48M | $-1.84 | -2046.3% | -2062.2% |
| 2014 | -$25M | -381.5% | -$24M | $-1.12 | -4441.3% | -4266.1% |
| 2013 | -$5M | -191.3% | -$3M | $-0.25 | -1099.2% | -719.6% |
| 2012 | -$2M | - | -$2M | $-0.09 | -6036.7% | -6053.3% |
Download Data
Export ADVM earnings history in CSV or JSON format
Free sign-in required to download data
ADVM Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ADVM — Frequently Asked Questions
Quick answers to the most common questions about buying ADVM stock.
What is ADVM earnings per share (EPS)?
ADVM trailing twelve-month (TTM) diluted EPS is $-8.70, reflecting -227.7% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2024 is available in the table on this page.
What is Adverum Biotechnologies, Inc.'s net income?
Adverum Biotechnologies, Inc. (ADVM) trailing twelve-month net income is $-204M as of 2024. Earnings declined -227.7% year-over-year.
Is ADVM profitable?
ADVM is not currently profitable on a TTM basis, reporting a net loss of $-204M. Net margin is -13092.7%. Investors should monitor for a return to profitability.
What is ADVM's earnings growth rate?
ADVM compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2024.
What are ADVM's profit margins?
Adverum Biotechnologies, Inc. net profit margin is -13092.7%, operating margin is -13915.9%, and gross margin is +100.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -189.8%.
Is ADVM growing earnings?
ADVM earnings are declining — EPS fell -227.7% year-over-year. TTM net income dropped to $-204M. This contrasts with the 5-year CAGR of N/A.
What was ADVM's best earnings year?
Adverum Biotechnologies, Inc.'s highest annual net income on record is $-2M, achieved in fiscal year 2012. Earnings history on this page spans 2012 to 2024 and includes all annual and quarterly figures.
What were ADVM's earnings last quarter?
ADVM's most recent reported quarter was Q3 2025. Net income was $-48M with diluted EPS of $-2.03. For a full breakdown of all quarters, see the quarterly earnings table on this page.